This announcement is a separate document:
国邦医药监事会关于公司第一期员工持股计划相关事项的核查意见
Verification opinion on the first phase of the company's employee shareholding plan by Guobang Pharmaceutical's supervisors.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Latest
02:38
Foreign ministers of Iraq, Iran, and Syria: The Syrian crisis must be addressed through peaceful means.
02:34
As of the week ending December 3, speculators in ICE Brent crude oil increased their net long positions by 26,076 contracts, reaching a total of 156,924 contracts.
02:28
The second largest auto manufacturer in europe, Stellantis NV, announced plans to rejoin the EU automotive lobbying group ACEA (European Automobile Manufacturers Association). The company withdrew from ACEA in June 2022 due to increasing pressure.
STLA+2.79%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.